iKNOWgynetics - A web-based learning concept to empower primary care gynecologists to participate in the care of patients with a family history of breast and ovarian cancer.
digital learning
education
familial cancer risk
genetic counseling
primary care
transsectoral care
Journal
Journal of genetic counseling
ISSN: 1573-3599
Titre abrégé: J Genet Couns
Pays: United States
ID NLM: 9206865
Informations de publication
Date de publication:
14 Jul 2023
14 Jul 2023
Historique:
revised:
01
06
2023
received:
07
06
2022
accepted:
26
06
2023
medline:
15
7
2023
pubmed:
15
7
2023
entrez:
15
7
2023
Statut:
aheadofprint
Résumé
Familial cancer burden and genetics play an increasingly important role in the early detection and prevention of gynecological cancers. However, people with hereditary cancer risks are often identified late when they already have cancer. We aimed at developing and evaluating a training concept for primary care gynecologists-iKNOWgynetics-to improve their knowledge and awareness of genetic cancer syndromes and their ability to identify patients with increased familial cancer risks based on up-to-date evidence and current guidelines (in Germany, primary care includes all doctors treating patients on an outpatient basis without a clear separation of the expertise of the doctor or of their specialty). Starting off with a needs assessment among primary care gynecologists, we developed and evaluated an online training concept-using a web-based learning platform in combination with a live virtual seminar-to convey practice-relevant knowledge about familial cancer. After registration, participants get access to the web-based learning platform (www.iknowgynetics.de) to prepare for the virtual seminars and to use it as online reference to re-access the contents after the training. Evaluation included multiple-choice (MC) questions on knowledge and participants' self-efficacy to implement the acquired knowledge, which were administered in a pre-post design. Of 109 participants, 103 (94.5%) filled out pre- and post-questionnaires. Eighty-five participants were gynecologists in primary care from Berlin (81.2%) and Brandenburg (18.8%) and had an average of 24.1 years (SD = 8.5 years) of professional experience. After the training, participants answered significantly more knowledge questions correctly (M = 15.2 of 17, SD = 1.3) than before (M = 13.8 of 17, SD = 1.7) (p < 0.01) and felt more confident to be able to apply referral criteria for specialized counseling in practice (p < 0.001). The online-based training iKNOWgynetics considers the busy schedule of primary care gynecologists and supports them in acquiring practice-relevant information on familial cancer risks and on how to identify healthy persons at risk, which may ultimately help to improve the prevention of gynecological cancers. In future studies, the reported concept could be transferred to other entities.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Deutsche Krebshilfe
ID : 70113238
Informations de copyright
© 2023 The Authors. Journal of Genetic Counseling published by Wiley Periodicals LLC on behalf of National Society of Genetic Counselors.
Références
Bellcross, C. A., Kolor, K., Goddard, K. A. B., Coates, R. J., Reyes, M., & Khoury, M. J. (2011). Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. American Journal of Preventive Medicine, 40(1), 61-66. https://doi.org/10.1016/j.amepre.2010.09.027
Bokkers, K., Zweemer, R. P., Koudijs, M. J., Stehouwer, S., Velthuizen, M. E., Bleiker, E. M. A., & Ausems, M. G. E. M. (2021). Positive experiences of healthcare professionals with a mainstreaming approach of germline genetic testing for women with ovarian cancer. Familial Cancer, 21, 295-304. https://doi.org/10.1007/s10689-021-00277-7
Cohen, S. A., Bradbury, A., Henderson, V., Hoskins, K., Bednar, E., & Arun, B. K. (2019). Genetic counseling and testing in a community setting: Quality, access, and efficiency. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, 39, e34-e44. https://doi.org/10.1200/EDBK_238937
Dekanek, E. W., Thull, D. L., Massart, M., Grubs, R. E., Rajkovic, A., & Mai, P. L. (2020). Knowledge and opinions regarding BRCA1 and BRCA2 genetic testing among primary care physicians. Journal of Genetic Counseling, 29(1), 122-130. https://doi.org/10.1002/jgc4.1189
Evans, O., & Manchanda, R. (2020). Population-based genetic testing for precision prevention. Cancer Prevention Research (Philadelphia, Pa.), 13(8), 643-648. https://doi.org/10.1158/1940-6207.CAPR-20-0002
Fechner, K., Haering, S., Kendel, F., Feufel, M., Olbrich, C., & Speiser, D. (2020). Role of resident gynecologists in the Care of Counselees with family cancer burden - A needs analysis. Journal of Oncology Research and Treatment, 43, 211-212.
Frank, C., Fallah, M., Sundquist, J., Hemminki, A., & Hemminki, K. (2015). Population landscape of familial cancer. Scientific Reports, 5, 12891. https://doi.org/10.1038/srep12891
Fussman, C., Schrager, J., & Duquette, D. (2016). Breast and ovarian cancer personal/family history and genetic counseling utilization among Michigan women. In Michigan BRFSS surveillance brief. Vol. 10, No. 3. Michigan Department of Health and Human Services, Lifecourse Epidemiology and Genomics Division.
Haga, S. B., Kim, E., Myers, R. A., & Ginsburg, G. S. (2019). Primary care Physicians' knowledge, attitudes, and experience with personal genetic testing. Journal of Personalized Medicine, 9(2), 1-14. https://doi.org/10.3390/jpm9020029
Institut für Medizinische und Pharmazeutische Prüfungsfragen (IMPP). (2020). https://www.impp.de/ (Accessed 15 June 2020).
Kne, A., Zierhut, H., Baldinger, S., Swenson, K. K., Mink, P., Veach, P., & Tsai, M. L. (2017). Why is cancer genetic counseling underutilized by women identified as at risk for hereditary breast cancer? Patient perceptions of barriers following a referral letter. Journal of Genetic Counseling, 26(4), 697-715. https://doi.org/10.1007/s10897-016-0040-0
Knerr, S., Bowles, E. J. A., Leppig, K. A., Buist, D. S. M., Gao, H., & Wernli, K. J. (2019). Trends in BRCA test utilization in an integrated health system, 2005-2015. Journal of the National Cancer Institute, 111(8), 795-802. https://doi.org/10.1093/jnci/djz008
Kühn, F., Karsten, M. M., Kendel, F., Feufel, M. A., & Speiser, D. (2021). Training courses on hereditary breast and ovarian cancer to strengthen cross-sectoral care in underserved areas. Patient Education and Counseling, 104(6), 1431-1437. https://doi.org/10.1016/j.pec.2020.10.035
Manchanda, R., Blyuss, O., Gaba, F., Gordeev, V. S., Jacobs, C., Burnell, M., Gan, C., Taylor, R., Turnbull, C., Legood, R., Zaikin, A., Antoniou, A. C., Menon, U., & Jacobs, I. (2018). Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population. Journal of Medical Genetics, 55(8), 538-545. https://doi.org/10.1136/jmedgenet-2017-105195
McCain, L. A., Milliron, K. J., Cook, A. M., Paquette, R., Parvaz, J. B., Ernst, S. D., Kittendorf, A. L., Harper, D. M., Zazove, P., Arthurs, J., Tippie, J. A., Hulswit, B., Schroeder, L. F., Keren, D. F., & Merajver, S. D. (2022). Implementation of INHERET, an online family history and cancer risk interpretation program for primary care and specialty clinics. Journal of the National Comprehensive Cancer Network: JNCCN, 20(1), 63-70. https://doi.org/10.6004/jnccn.2021.7072
McCarthy, A. M., Bristol, M., Fredricks, T., Wilkins, L., Roelfsema, I., Liao, K., Shea, J. A., Groeneveld, P., Domchek, S. M., & Armstrong, K. (2013). Are physician recommendations for BRCA1/2 testing in patients with breast cancer appropriate? A population-based study. Cancer, 119(20), 3596-3603. https://doi.org/10.1002/cncr.28268
Meiser, B., Woodward, P., Gleeson, M., Kentwell, M., Fan, H. M., Antill, Y., Butow, P. N., Boyle, F., Best, M., Taylor, N., Bell, K., & Tucker, K. (2022). Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patients. Familial Cancer, 21(2), 157-166. https://doi.org/10.1007/s10689-021-00261-1
Meyer, L. A., Anderson, M. E., Lacour, R. A., Suri, A., Daniels, M. S., Urbauer, D. L., Nogueras-Gonzalez, G. M., Schmeler, K. M., Gershenson, D. M., & Lu, K. H. (2010). Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: Missed opportunities. Obstetrics and Gynecology, 115(5), 945-952. https://doi.org/10.1097/AOG.0b013e3181da08d7
Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Doubeni, C. A., Epling, J. W., Jr., Kubik, M., Landefeld, C. S., Mangione, C. M., Pbert, L., Silverstein, M., Simon, M. A., Tseng, C. W., & Wong, J. B. (2019). Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer: US preventive services task force recommendation Statement. JAMA, 322(7), 652-665. https://doi.org/10.1001/jama.2019.10987
Ritchie, J. B., Welch, B. M., Allen, C. G., Frey, L. J., Morrison, H., Schiffman, J. D., Alekseyenko, A. V., Dean, B., Hughes Halbert, C., & Bellcross, C. (2021). Comparison of a cancer family history collection and risk assessment tool - ItRunsInMyFamily - with risk assessment by health-care professionals. Public Health Genomics, 1-9, 1-9. https://doi.org/10.1159/000520001
Stadler, Z. K., Maio, A., Chakravarty, D., Kemel, Y., Sheehan, M., Salo-Mullen, E., Tkachuk, K., Fong, C. J., Nguyen, B., Erakky, A., Cadoo, K., Liu, Y., Carlo, M. I., Latham, A., Zhang, H., Kundra, R., Smith, S., Galle, J., Aghajanian, C., … Robson, M. E. (2021). Therapeutic implications of germline testing in patients with advanced cancers. Journal of Clinical Oncology, 39(24), 2698-2709. https://doi.org/10.1200/JCO.20.03661
Sussner, K. M., Jandorf, L., & Valdimarsdottir, H. B. (2011). Educational needs about cancer family history and genetic counseling for cancer risk among frontline healthcare clinicians in New York City. Genetics in Medicine, 13(9), 785-793. https://doi.org/10.1097/GIM.0b013e31821afc8e
van Riel, E., van Dulmen, S., & Ausems, M. G. E. M. (2012). Who is being referred to cancer genetic counseling? Characteristics of counselees and their referral. Journal of Community Genetics, 3(4), 265-274. https://doi.org/10.1007/s12687-012-0090-4
van Riel, E., Wárlám-Rodenhuis, C. C., Verhoef, S., Rutgers, E. J. T. H., & Ausems, M. G. E. M. (2010). BRCA testing of breast cancer patients: Medical specialists' referral patterns, knowledge and attitudes to genetic testing. European Journal of Cancer Care, 19(3), 369-376. https://doi.org/10.1111/j.1365-2354.2008.01065.x
Welch, B. M., Wiley, K., Pflieger, L., Achiangia, R., Baker, K., Hughes-Halbert, C., Morrison, H., Schiffman, J., & Doerr, M. (2018). Review and comparison of electronic patient-facing family health history tools. Journal of Genetic Counseling, 27(2), 381-391. https://doi.org/10.1007/s10897-018-0235-7
Xiao, Y. L., Wang, K., Liu, Q., Li, J., Zhang, X., & Li, H. Y. (2019). Risk reduction and survival benefit of risk-reducing Salpingo-oophorectomy in hereditary breast cancer: Meta-analysis and systematic review. Clinical Breast Cancer, 19(1), e48-e65. https://doi.org/10.1016/j.clbc.2018.09.011